ReSync Bio, a technology company providing AI-enabled drug discovery solutions, today announced that it has integrated NVIDIA ...

The TxGemma models are – as the name suggests – an offshoot of Google's Gemma family of open-source, generative AI (GenAI) ...

Google Cloud will also be among the first to adopt Nvidias GB300 NVL72 and RTX PRO 6000 Blackwell Server Edition GPUs.

Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

Artificial intelligence can help. The stories below highlight startup companies that use AI to spot patterns that humans ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

Scientists have developed a revolutionary AI ‘fingerprint’ technology that can accurately show how cancer cells respond to ...